Last reviewed · How we verify
NCT04869865
The Effects of a Springtime Home Cleanse on Skin, Gut, Metabolic and Mental Health
NA trial testing 9-day detoxification cleanse and 1 week of pre-cleanse transition in Healthy in 18 participants. Status unknown.
3 April 2022
Quick facts
| Lead sponsor | Integrative Skin Science and Research |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 18 |
| Start date | 29 April 2021 |
| Primary completion | 3 April 2022 |
| Estimated completion | 3 April 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- 9-day detoxification cleanse and 1 week of pre-cleanse transition
Conditions studied
- Healthy — all drugs for Healthy →
Sponsor
Integrative Skin Science and Research
Who can join
Adults 18 to 69, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This pilot study will evaluate the effects of a Springtime Home Cleanse on skin, gut, metabolic, and mental health. The study will also assess changes in overall quality of life. The results will be used to design a larger cleanse-based study in the future.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Clinical Measurement of Transepidermal Water Loss.
Kundu D, Jayaraman A, Sen CK. · · 2026 · cited 4× · PMID 40476522 · DOI 10.1089/wound.2024.0148
Verify or expand the search:
- PubMed search for NCT04869865
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other Integrative Skin Science and Research trials
Trials by the same sponsor.
- NCT06571721 — The Effects of Topical Almond Oil and Tretinoin on Facial Wrinkles · NA · recruiting
- NCT06146166 — The Effects of an Oral Hair Supplement on Hair Density, Growth, and Microbiome · NA · active not recruiting
- NCT06146140 — Effects of an Oral Herbal Supplement on Skin Aging, Hydration, and Elasticity · NA · unknown
- NCT06072066 — Effects of Oral Supplement Containing L-Histidine and Antioxidants on the Skin Barrier Function and Systemic Inflammatio · NA · recruiting
- NCT06142487 — Assessment of the Effects of Silk Pillowcases on Acne Prone Skin · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04869865 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Integrative Skin Science and Research
- Last refreshed: 3 May 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04869865.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing